Centromere Protein I, a Cell Cycle Checkpoint Gene, Accelerates Tumor Progression via the Hippo Pathway and Mediates Immune Escape in Hepatocellular Carcinoma

Risheng He, Yi Xu, Pengbo Zhang, Liang Yu, Jian Ma, Yunfu Cui

[ Html ] [ PDF ] 1019-1035

doi:10.14218/JCTH.2025.00127

Longitudinal Profile of HBsAg Isoforms and Circulating Immune Complexes in the Natural History of Chronic Hepatitis B Infection

Lung-Yi Mak, Mark Anderson, Tiffany Fortney, Danny Ka-Ho Wong, Rex Wan-Hin Hui, Wai-Kay Seto, Gavin Cloherty, Man-Fung Yuen

[ Html ] [ PDF ] 1122-1125

doi:10.14218/JCTH.2025.00379

IL1RA⁺ Myeloid-derived Suppressor Cells Activate Epithelial-mesenchymal Transition to Facilitate Lymphatic and Hepatic Metastasis in Pancreatic Ductal Carcinoma

Huan Liu, Jian Zhang, Shengnan Lv, Xinyu Peng, Han Liu, Haijun Li, Feng Wei

[ Html ] [ PDF ] 935-948

doi:10.14218/JCTH.2025.00416

Intrahepatic Cholestasis of Pregnancy: A Hot Topic Commentary

Bianca Thakkar, George Y. Wu

[ Html ] [ PDF ] 1015-1017

doi:10.14218/JCTH.2025.00381

Corrigendum: Mitochondrial Membrane Potential of CD8⁺ T Cells Predicts Bacterial Infection and Rapid Development of Acute-on-chronic Liver Failure in Cirrhotic Patients

[ Html ] [ PDF ] 904-904

doi:10.14218/JCTH.2024.00452C

Consensus on the Management of Liver Injury Associated with Targeted Drugs and Immune Checkpoint Inhibitors for Hepatocellular Carcinoma (Version 2024)

Suxian Zhao, Jie Li, Lingdi Liu, Sha Huang, Yanhang Gao, Mei Liu, Yu Chen, Lai Wei, Jidong Jia, Hong You, Zhongping Duan, Hui Zhuang, Jingfeng Liu, Xiaoyuan Xu, Yuemin Nan, Chinese Society of Hepatology, Chinese Medical Association

[ Html ] [ PDF ] 992-1005

doi:10.14218/JCTH.2025.00228

Research Progress on Leptin in Metabolic Dysfunction-associated Fatty Liver Disease

Jian-Li Wang, Yue Xiao, Ming-Long Li, Guo-Li Chen, Miao-Hang Cui, Jin-Long Liu

[ Html ] [ PDF ] 964-975

doi:10.14218/JCTH.2025.00204

Hepatosplenic Volumes and Portal Pressure Gradient Identify One-year Further Decompensation Risk Post-transjugular Intrahepatic Portosystemic Shunt

Xinyu Chen, Yicheng Lin, Kefeng Jia, Rong Lv, Jiajun Tian, Fenghui Li, Jun Li, Yiwen Zhang, Ning Wang, Zhongsong Gao, Weili Yin, Fang Wang, Ping Zhu, Chao Yang, Jiayin Wang, Tao Wang, Junqing Yan, Ying Liu, Qing Ye, Huiling Xiang

[ Html ] [ PDF ] 835-846

doi:10.14218/JCTH.2025.00199

The Role of Hepatic SIRT1: From Metabolic Regulation to Immune Modulation and Multi-target Therapeutic Strategies

Houyan Zhang, Dongjie Wu, Qingjuan Wu, Yanxuan Wu, Ziwei Guo, Li Wang, Yi Wang, Qian Zeng, Liang Shi, Bin Shi, Gongchang Yu, Wenliang Lv

[ Html ] [ PDF ] 878-898

doi:10.14218/JCTH.2025.00259

The Mechanisms behind Thrombocytopenia in Patients with Portal Hypertension and Chronic Liver Disease

Valeria M. Fernández-Garibay, Mariana M. Ramírez-Mejia, Guadalupe Ponciano-Rodriguez, Ran Wang, Xingshun Qi, Nahum Méndez-Sánchez

[ Html ] [ PDF ] 986-991

doi:10.14218/JCTH.2025.00279

Mapping Metabolic Dysfunction-associated Steatotic Liver Disease Models of Care across 17 Middle East and North Africa Countries: Insights into Guidelines, Infrastructure, and Referral Systems

Mohamed El-Kassas, Khalid M. AlNaamani, Rofida Khalifa, Yusuf Yilmaz, Asma Labidi, Maen Almattooq, Faisal M. Sanai, Maisam W.I. Akroush Nabil Debzi, Mohammed A. Medhat, Imam Waked, Ali Tumi, Mohamed Elbadry, Mohammed Omer Mohammed, Ala I. Sharara, Ali El Houni, Mohamed Alsenbesy, Hisham El-Khayat, Mina Tharwat, Abdel-Naser Elzouki, Khalid A. Alswat, Zobair M. Younossi, on behalf of the Steatotic Liver Disease Study Foundation in Middle East and North Africa (SLMENA) Collaborators

[ Html ] [ PDF ] 791-808

doi:10.14218/JCTH.2025.00286

Autoimmune Hepatitis Associated with Other Autoimmune Diseases: A Critical Review

Danzhu Zhao, George Y. Wu

[ Html ] [ PDF ] 869-877

doi:10.14218/JCTH.2025.00153